MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 59 filers reported holding MENLO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $86,000 | +6.2% | 49,339 | +63.8% | 0.00% | – |
| Q1 2020 | $81,000 | -38.2% | 30,121 | +5.9% | 0.00% | – |
| Q4 2019 | $131,000 | +0.8% | 28,451 | -2.8% | 0.00% | – |
| Q3 2019 | $130,000 | -53.9% | 29,274 | -38.0% | 0.00% | – |
| Q2 2019 | $282,000 | +166.0% | 47,239 | +246.1% | 0.00% | – |
| Q1 2019 | $106,000 | -12.4% | 13,647 | -54.0% | 0.00% | – |
| Q4 2018 | $121,000 | -84.2% | 29,651 | -61.9% | 0.00% | – |
| Q3 2018 | $765,000 | +257.5% | 77,792 | +193.9% | 0.00% | – |
| Q2 2018 | $214,000 | -31.0% | 26,469 | +219.2% | 0.00% | – |
| Q1 2018 | $310,000 | – | 8,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners L.P. | 1,461,552 | $11,868,000 | 12.24% |
| Vivo Capital, LLC | 4,011,236 | $32,571,000 | 4.20% |
| DAFNA Capital Management LLC | 312,000 | $2,533,000 | 1.19% |
| Novo Holdings A/S | 1,436,313 | $11,663,000 | 1.17% |
| Perceptive Advisors | 1,241,287 | $10,079,000 | 0.26% |
| Rock Springs Capital Management LP | 330,000 | $2,680,000 | 0.10% |
| Baker Brothers Advisors | 700,000 | $5,684,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 50,000 | $406,000 | 0.02% |
| A.R.T. Advisors, LLC | 31,703 | $257,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 2,036,111 | $16,533,000 | 0.01% |